Journal article
Validation of a brief tool to assess and monitor suicidal ideation: The Youth Suicide Ideation Screen (YSIS-3)
SE Hetrick, CX Gao, KM Filia, JM Menssink, DJ Rickwood, H Herrman, I Hickie, P McGorry, N Telford, AG Parker, SM Cotton
Journal of Affective Disorders | Published : 2021
Abstract
Background:. Suicidal ideation is common in young people. Assessment and monitoring can help to understand its dynamic nature and inform treatment planning. Aims:. The aims were to evaluate psychometric properties of a brief screening tool - the Youth Suicide Ideation Screen-3 item (YSIS-3) and determine its correlation with the Suicidal Ideation Question-Junior (SIQ-JR) and measures of depressive and anxiety symptoms a. Method:. Cronbach's alpha (α) was used to evaluate internal consistency of the YSIS-3 in 1107 young people. Convergent validity was evaluated using network analysis based on individual item polychoric correlations. Structural equation modelling was used to understand latent ..
View full abstractRelated Projects (2)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This study was funded by the Australian National Health and Medical Research Council (NHMRC, APP1076940). This was a joint project between Orygen, The University of Melbourne, and headspace National Youth Mental Health Foundation. Sarah Hetrick is funded by an Auckland Medical Research Foundation Douglas Goodfellow Repatriation Fellowship and CureKids. She is the joint co-ordinating editor of the Cochrane Common Mental Disorders (CCMD) Group and lead of the Children and Young People Satellite of the CCMD. Sue Cotton is funded by a NHMRC Senior Research Fellowship (APP1136344). Debra Rickwood is Chief Scientific Advisor to headspace and Professor of Psychology at the University of Canberra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Instructions for use The YSIS-3 is a free tool designed to evaluate suicidal thoughts among adolescents and young adults. The YSIS-3 can be used in research and clinical practice, both as a screening tool to indicate need of further assessment and as an outcome monitoring tool to assist clinical treatment and intervention. Any scores of 1+ require further investigation.